IGF-1 LR3

IGF-1 LR3 and Anti-Doping Status

UKPWritten and published by UK Peptides1 min readUpdated 3 cited sources

The short answer

IGF-1 and its analogues appear on the WADA Prohibited List under class S2, peptide hormones, growth factors, related substances and mimetics,prohibited at all times, both in and out of competition.

Key facts

WADA class
S2
Class covers
Peptide hormones, growth factors, mimetics
Prohibited
At all times (in and out of competition)
Covers analogues
Yes (engineered forms included)
Also in S2
Growth hormone and its secretagogues
Marketing authorisation
None for LR3

What class S2 is

Peptide hormones, growth factors, related substances and mimetics. It covers growth hormone, its releasing factors and secretagogues, erythropoietin and related agents, and the IGF-1 family. These are substances that act on endogenous signalling systems, which is what groups them.

What prohibited at all times means

Some substances are prohibited only in competition, on the reasoning that their effect is acute. S2 substances are prohibited in and out of competition, because their effects develop over time and out-of-competition use would otherwise carry the benefit into competition. Testing applies year-round.

Research material referenced

IGF-1 LR3 1mg, third-party HPLC tested

Buy IGF-1 LR3 · £49.99

Why analogues are covered explicitly

The list names substances and then extends to related substances and mimetics, so that a structural modification does not create an exemption. An engineered IGF-1 analogue with an N-terminal extension and a substitution is squarely within that scope. The modification is the reason the wording exists.

The separate regulatory position

Anti-doping and medicines regulation are different frameworks. IGF-1 LR3 holds no marketing authorisation from any regulator, which is a separate fact from its prohibited status. A compound can be prohibited in sport and licensed as a medicine (mecasermin is) or, as here, prohibited and unlicensed both.

Why this site states it clearly

Because anyone competing under an anti-doping code needs the information without having to infer it. Material supplied here is for laboratory research only, and nothing about the research context alters what the Prohibited List covers.

Frequently asked questions

Is IGF-1 LR3 banned in sport?

Yes. IGF-1 and its analogues are in WADA class S2, prohibited at all times in and out of competition.

Does modifying the molecule avoid the classification?

No. The list extends to related substances and mimetics specifically so that structural modification creates no exemption.

Is prohibited status the same as being unlicensed?

No, they are separate frameworks. LR3 happens to be both prohibited in sport and unlicensed as a medicine.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More IGF-1 LR3 articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.